Patent details

EP1173186 Title: USE OF TAGATOSE TO ENHANCE KEY BLOOD FACTORS

Basic Information

Publication number:
EP1173186
PCT Application Number:
PCT/US/2000/008882
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009216482
PCT Publication Number:
WO/2000/064451
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF TAGATOSE TO ENHANCE KEY BLOOD FACTORS
French Title of Invention:
UTILISATION DE TAGATOSE AFIN D'AUGMENTER DES FACTEURS SANGUINS CLES
German Title of Invention:
VERWENDUNG VON TAGATOSE ZUR VERBESSERUNG WICHTIGER BLUTFAKTOREN
SPC Number:

Dates

Filing date:
04/04/2000
Grant date:
14/06/2006
EP Publication Date:
14/06/2006
PCT Publication Date:
02/11/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/01/2002
EP B1 Publication Date:
14/06/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/04/2007
Expiration date:
04/04/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/04/2000
 
 

Name:
Biospherics Incorporated
Address:
12051 Indian Creek Court, Beltsville, MD 21403, United States (US)

Inventor

Name:
LEVIN Gilbert
Address:
United States (US)

Priority

Priority Number:
299023
Priority Date:
26/04/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/70;
Filing date Document type Number of pages